Neurotoxicity of intraventricularly administered alpha-interferon for leptomeningeal disease

Cancer. 1991 Jul 1;68(1):88-92. doi: 10.1002/1097-0142(19910701)68:1<88::aid-cncr2820680118>3.0.co;2-5.

Abstract

Nine patients with leptomeningeal disease are reported who were treated with intraventricular alpha-interferon (alpha-IFN). In seven of these patients, a progressive vegetative state developed during treatment. The patients became unresponsive to verbal commands but opened their eyes with auditory or tactile stimulation. It took an average of 3 weeks for these patients to become verbally responsive after treatment was discontinued. Electroencephalographic findings showed evidence of irritative involvement of the deep midline nuclei in 80% of patients. Periventricular white matter changes developed during treatment in three of six patients who underwent computed tomographic scans. All patients with this severe neurotoxicity received whole-brain irradiation before treatment. Possible mechanisms for the development of this neurotoxic syndrome are discussed. The neurotoxicity of alpha-IFN and brain irradiation may be additive, suggesting a cautious approach when using this combination for treatment.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Breast Neoplasms / pathology
  • Coma / diagnosis
  • Coma / etiology*
  • Drug Evaluation
  • Electroencephalography
  • Female
  • Humans
  • Interferon Type I / adverse effects*
  • Lung Neoplasms / pathology
  • Lymphoma / pathology
  • Male
  • Melanoma / drug therapy
  • Melanoma / secondary
  • Meningeal Neoplasms / drug therapy*
  • Meningeal Neoplasms / mortality
  • Meningeal Neoplasms / radiotherapy
  • Meningeal Neoplasms / secondary
  • Middle Aged
  • Survival Rate
  • Tomography, X-Ray Computed

Substances

  • Interferon Type I